Valuation: Sysmex Corporation

Market Cap 1,175B 7.46B 6.68B 6.15B 5.57B 10.41B 708B 10.6B 73.28B 29.42B 373B 28B 27.4B P/E 2027 *
29.3x
P/E 2028 * 23.9x
Enterprise Value 1,196B 7.59B 6.8B 6.26B 5.67B 10.6B 721B 10.79B 74.6B 29.95B 379B 28.5B 27.89B EV / Sales 2027 *
2.18x
EV / Sales 2028 * 2.07x
Free-Float
71.34%
Yield 2027 *
2.08%
Yield 2028 * 2.16%
1 day+0.65%
1 week+0.13%
1 month+5.23%
3 months+21.42%
6 months+40.89%
Current year+25.87%
1 week 1,892
Extreme 1892
1,976.5
1 month 1,807.5
Extreme 1807.5
2,025
Current year 1,246
Extreme 1246
2,025
1 year 1,246
Extreme 1246
2,025
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 77 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 77 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.65%+0.13%+12.42%-18.57% 7.46B
+1.56%+2.41%-14.09%+12.32% 184B
-0.59%+1.18%+6.44%+36.82% 118B
-6.38%-4.98%-18.07%+8.01% 111B
+3.42%+1.71%-41.92%+8.01% 94.58B
+0.09%-0.05%-2.06%+78.69% 63.13B
-0.46%+0.42%+4.48%+82.84% 55.66B
-0.23%-0.52%+10.73%-21.72% 53.9B
-4.30%-1.64%-12.44%+37.99% 43.42B
+0.58%+2.00%-1.17%-8.82% 34.68B
Average -0.57%+0.07%-5.57%+21.56% 76.59B
Weighted average by Cap. -0.47%+0.24%-9.91%+23.34%

Financials

2027 *2028 *
Net sales 549B 3.48B 3.12B 2.87B 2.6B 4.86B 331B 4.95B 34.23B 13.74B 174B 13.07B 12.8B 577B 3.67B 3.28B 3.02B 2.74B 5.12B 348B 5.21B 36.02B 14.46B 183B 13.76B 13.47B
Net income 40.33B 256M 229M 211M 191M 357M 24.31B 364M 2.52B 1.01B 12.79B 961M 940M 49.35B 313M 281M 258M 234M 437M 29.75B 445M 3.08B 1.24B 15.65B 1.18B 1.15B
Net Debt 21.13B 134M 120M 111M 100M 187M 12.74B 191M 1.32B 529M 6.7B 503M 493M 20.46B 130M 116M 107M 96.94M 181M 12.33B 185M 1.28B 512M 6.49B 487M 477M
Projected Income Statement - Annual - Sysmex Corporation
Logo Sysmex Corporation
SYSMEX CORPORATION is a Japan-based company engaged in the development, manufacture, sale, servicing and import/export of clinical testing instruments and reagents for the medical field. It proposes solutions to address the diverse challenges faced by medical institutions by integrating a wide range of products and services, including software, maintenance for clinical testing equipment, and academic support. It operates business through four segments centered on regional controlling entity, including Headquarters, Americas, Europe, Middle East and Africa (EMEA), China and Asia-Pacific (AP). Headquarters segment operates with the Company itself acting as the controlling entity, responsible for product development, manufacture and others, consolidated subsidiaries within this segment handle the development and manufacturing of certain products, as well as domestic and overseas sales. Americas, Europe, EMEA, China and AP segments operate business in their respective regions.
Employees
10,861
Date Price Change Volume
30/10/26 ¥1,941.50 +0.65% 3,747,800
29/10/26 ¥1,929.00 -0.34% 3,875,300
28/10/26 ¥1,935.50 -1.12% 1,718,500
27/10/26 ¥1,957.50 -0.28% 1,981,200
26/10/26 ¥1,963.00 +1.24% 2,024,100
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Sysmex Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,941.50JPY
Average target price
2,139.29JPY
Spread / Average Target
+10.19%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sysmex Corporation
  1. Stock Market
  2. Stocks
  3. 6869 Stock